Table 2. Perioperative and postoperative outcomes of patients.
| Variable | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
| Operative time (min) | 100 | 118 | 248 |
| Docking time (min) | 9 | 12 | 19 |
| Console time (min) | 80 | 93 | 206 |
| WIT (min) | 23 | 21 | 55 |
| Estimated blood loss (mL) | 30 | 10 | 550 |
| Preoperative hemoglobin (g/dL) | 12.10 | 17.2 | 16.7 |
| Postoperative hemoglobin (g/dL) | 12.00 | 15.8 | 13.5 |
| Transfusion | None | None | None |
| Preoperative eGFR (mL/min/1.73 m2) | 75.2 | 112.0 | 76.8 |
| Latest eGFR (mL/min/1.73 m2) | 67.4 | 105.7 | 54.0 |
| Positive surgical margins | Negative | Negative | Negative |
| Clavien-Dindo complications | 0 | 0 | 1 |
| Hospitalization (d) | 3 | 2 | 7 |
| pTNM stage | T1bN0M0 | T1aN0M0 | T1aN0M0 |
| Pathology (ISUP Nucleolar grade) | Chromophobe RCC (grade II) | Clear cell RCC (grade III) | Clear cell RCC (grade III) |
WIT, warm ischemic time; eGFR, estimated glomerular filtration rate; RCC, renal cell carcinoma.